Hospital‐initiated medication review – time to deliver on a decade of promises

Author:

Criddle Deirdre1ORCID,Angley Manya2,Thiele Horst3,Gailer Joy4,Phillips Katie5,Page Amy6ORCID,Pauw Carly7

Affiliation:

1. Pharmacy Department Sir Charles Gairdner Hospital Perth Australia

2. Manya Angley Research & Consulting (MARAC) Adelaide Australia

3. Acute/Post‐Acute Care (HITH) Northern Sydney Local Health District St Leonards Australia

4. Drug and Therapeutics Information Service Southern Adelaide Local Health Network Adelaide Australia

5. Royal Melbourne Hospital HARP Melbourne Melbourne Australia

6. Pharmacy Department Alfred Hospital Melbourne Australia

7. Western Sydney Local Health District Post Acute Community Care, Hospital in the Home Penrith Penrith Australia

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacy

Reference6 articles.

1. Feasibility and Timeliness of Alternatives to Post‐Discharge Home Medicines Reviews for High‐Risk Patients

2. Department of Health (Australian Government).Implementation of a hospital referral pathway to enable urgent Home Medicines Reviews (HMR).2020.Canberra:Department of Health. Available from .

3. Department of Health (Australian Government).Medicines Home Review Hospital Referral Pathway.2020.Canberra:Department of Health. Available from

4. SHPA Transitions of Care and Primary Care Interest Group Discussion Forum.Discussion topic 'Government response to Aged Care Royal Commission'. Available fromhttps://shpa.moodle.com.au/mod/forum/discuss.php?d=8494>

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3